Public Joint-Stock Company "Pharmsynthez"

MISX:LIFE Stock Report

Market Cap: ₽1.4b

Pharmsynthez Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Petr Kurglyakov

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureno data
Board average tenure9.8yrs

Recent management updates

Recent updates

CEO

Petr Kurglyakov (44 yo)

no data

Tenure

Mr. Petr Vladimirovich Kurglyakov serves as Director General at Public Joint-Stock Company Pharmsynthez. Mr. Kurglyakov graduated from Saint Petersburg State University.

Board Members

NamePositionTenureCompensationOwnership
Surkov Gennadievich
Head of Research & Department and Member of Audit Commission4.3yrsno data0.000080%
RUB 1.1k
Dmitry Kolosov
Director9.8yrsno datano data
Indrek Kasela
Director15.8yrsno datano data
Dmitry Genkin
Executive Chairman17.8yrsno data0.00017%
RUB 2.3k
Steven Gorelik
Director15.8yrsno datano data
Olga Shpichko
Director9.7yrsno datano data
Roman Knyazev
Director9.7yrsno datano data
Aleksandr Zaporozhtsev
Member of Audit Commissionno datano datano data
Artem Orlov
Director9.8yrsno datano data
Irina Ivina
Member of Audit Commissionno datano datano data
Nina Podkolzina
Member of Audit Commissionno datano datano data
Valentin Zubov
Member of Audit Commission4.3yrsno datano data

9.8yrs

Average Tenure

48yo

Average Age

Experienced Board: LIFE's board of directors are considered experienced (9.8 years average tenure).